Share
Markers in Cancer: A joint meeting by ASCO, EORTC and NCI
November 7, 2013 - November 9, 2013
Venue: Brussels, Belgium
Next generation sequencing and high throughput screening technologies are revolutionizing our current molecular understanding of cancer. Molecular tumor profiles can now be established at affordable cost within a timeframe compatible with clinical practice. It is anticipated, that biomarker-based patient selection will soon move to the forefront of effective cancer treatment.
Markers in Cancer, a joint meeting by ASCO, EORTC & NCI, will focus on the relevance and the feasibility of implementing emerging technologies into clinical practice.
A tutorial on biomarker development dealing with issues related to next generation trial design (5-7 November 2013) will precede the Main Meeting and is open to early career oncologists.
Next events
EORTC Brain Tumour Group Autumn Meeting
September 14
Vienna, AT
CDDF Multi Stakeholder Workshop September 2022
September 19 - September 20
EORTC Quality of Life Group Autumn Meeting
September 21 - September 23
Amsterdam, NL
Cutaneous Lymphoma Tumours Group Annual Meeting
September 22 - September 24
Madrid, Spain
EORTC Gynecological Cancer Group Autumn Meeting
September 29
EORTC HQ, Brussels, Belgium